Search

everythinglearnresearchcommunity

for

Search:↓

The photographic method accurately measures hair growth and both treatments effectively reduced hair growth in hirsute women.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Oral Apremilast effectively treats alopecia areata in most patients.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Supplemented Erzhi Wan may help regrow hair in male pattern baldness by affecting certain cell signaling pathways.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Both laser treatments improved acne scars similarly, but the Nd:YAG laser was safer and less painful, while the Er:YAG laser left patients slightly more satisfied.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

0.05% betamethasone dipropionate is the most effective treatment for mild alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Injectable platelet-rich fibrin is a safe and effective treatment for hair loss.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.